Article
De novo variants in exomes of congenital heart disease patients identify risk genes and pathways.
Genome medicine - 15 Jan 2020
Sevim Bayrak Cigdem, Zhang Peng, Tristani-Firouzi Martin, Gelb Bruce D, Itan Yuval
Abstract excerpt
BACKGROUND: Congenital heart disease (CHD) affects ~ 1% of live births and is the most common birth defect. Although the genetic contribution to the CHD has been long suspected, it has only been well established recently. De novo variants are estimated to contribute to approximately 8% of sporadic CHD. METHODS: CHD is genetically heterogeneous, making pathway enrichment analysis an effective approach to explore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
